Here are three notes.
1. Analysts gave AmSurg shares a $94.33 price target
2. The shares have a rating of 1.2, indicating a “buy” rating.
3. During the most recent quarter, AmSurg’s earnings per share totaled $1.01.
More articles on surgery centers:
Analysts give SCA a $53.15 price target — 6 notes
CHI St. Luke’s pursues ASC expansion plans in Houston, acquires & rebrands Woodlands Ambulatory Surgery Center — 4 key takeaways
Nobilis shares rally 45.6% in 3 months — 4 notes
Next Up in ASC Transactions & Valuation Issues
-
The Medicare Payment Advisory Commission released its annual report to Congress March 12, which revealed key data points about the…
-
A new Federal Trade Commission study found that primary care is far less concentrated than many physician specialties, with just…
-
Gainesville, Fla.-based University of Florida Heath cut the ribbon on the UF Health Orthopaedic Surgical Center. The 24,000-square-foot facility, located…
Join the 40,000+ ASC leaders who start their day with Becker's
